会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明申请
    • Methods and compositions for screening and treatment of disorders of blood glucose regulation
    • 用于筛选和治疗血糖调节障碍的方法和组合物
    • US20080280955A1
    • 2008-11-13
    • US11541495
    • 2006-09-29
    • Mark A. McCamish
    • Mark A. McCamish
    • A61K31/4436C12Q1/68C07H21/04C07K2/00
    • C12Q1/6883C12Q2600/106C12Q2600/156C12Q2600/158C12Q2600/172
    • In one aspect, the invention provides a method of screening and, optionally, treatment of an individual suffering from an insulin resistance disorder by screening an individual in need of treatment for an insulin resistance disorder for one or more genetic variations indicating a predisposition to a response to an insulin sensitizer; and, optionally, administering or not administering an insulin sensitizer to the individual based on the results of the screening. The insulin sensitizer for which the individual is screened and the insulin sensitizer that is administered or not administered may be the same or different. In another aspect, the invention provides methods comprising identifying one or more genetic variations, e.g., one or more single nucleotide polymorphisms, that at least partly differentiate between a subset of a plurality of individuals who experience a response when administered an insulin sensitizer, and a subset of said plurality of individuals who do not experience a response when administered the insulin sensitizer. The invention also provides nucleic acids, polypeptides, antibodies, kits, and business methods associated with these screening and association methods.
    • 在一个方面,本发明提供了筛选和任选地治疗患有胰岛素抵抗障碍的个体的方法,其通过筛选需要治疗胰岛素抵抗障碍的个体对一种或多种指示反应倾向的遗传变异 胰岛素敏化剂; 以及任选地,基于筛选结果向个体施用或不施用胰岛素敏化剂。 筛选个体的胰岛素敏化剂和施用或未施用的胰岛素敏化剂可以相同或不同。 在另一方面,本发明提供了包括鉴定一种或多种遗传变异(例如,一种或多种单核苷酸多态性)的方法,其在施用胰岛素敏化剂时经历响应的多个个体的亚组中的至少一部分区别,以及 在施用胰岛素敏化剂时不经历反应的所述多个个体的子集。 本发明还提供与这些筛选和结合方法相关联的核酸,多肽,抗体,试剂盒和商业方法。